Tumor necrosis factor (
TNF)-alpha-induced phosphorylation of the IkappaB
proteins by the
IkappaB kinase (IKK) complex containing IKK-2 and subsequent degradation of the IkappaB
proteins are prerequisites for
NF-kappaB activation, resulting in the stimulation of a variety of pro-inflammatory target genes. The
C-C chemokine eotaxin-1 is a potent
chemoattractant for eosinophils and Th2 lymphocytes, may play an important role in the pathogenesis of
atopic dermatitis, and acts via binding to its
receptor CCR3. To investigate the role of
NF-kappaB signaling in the regulation of these genes, we stably expressed a transdominant mutant of
IkappaBalpha and a constitutively active mutant of IKK-2 in mouse NIH3T3 fibroblasts. The transdominant
IkappaBalpha mutant completely inhibited
TNF-alpha-mediated induction of both
eotaxin-1 and CCR3, whereas expression of constitutively active IKK-2 was sufficient to drive almost full expression of these two genes in the absence of
TNF-alpha. Moreover, we observed elevated expression levels of CCR3 and
eotaxin-1 protein levels in the skin of
IkappaBalpha-deficient mice characterized by a widespread
dermatitis. Finally, using dermal fibroblasts derived from
IkappaBalpha-deficient mice, we observed elevated basal expression, enhanced inducibility by
TNF-alpha, and attenuated down-regulation upon
TNF-alpha withdrawal of both CCR3 and
eotaxin-1 mRNA levels. These results demonstrate that the IKK-2/
IkappaBalpha/
NF-kappaB pathway plays a critical role for CCR3 and
eotaxin-1 expression in fibroblasts and suggests a critical link to the pathogenesis of
atopic dermatitis.